Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-29

Clinical Trial Update: Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating the Ejiao Compound for postpartum anemia due to Qi-blood deficiency; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ejiao Compound

Snippet

Sponsor: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | Conditions: Postpartum Anemia | Phase 1, Phase 2 | Status: UNKNOWN